hTERT-induced natural T cells therapy(Eutilex)

N/A

Report date: 2024/07/18 17:33:12

Base Information

Drug NamehTERT-induced natural T cells therapy(Eutilex)
Drug Alias NameTERTiNTs
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacementsTumor necrosis factor receptor superfamily member 9 modulators
TargetsTumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEutilex
China Registration ClassN/A

Develop Information

Active CompaniesEutilex
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A